VE-statin, an endothelial repressor of smooth muscle cell migration - Wikidata - wikimedia - TriplyDB

VE-statin, an endothelial repressor of smooth muscle cell migration

VE-statin, an endothelial repressor of smooth muscle cell migration

http://www.wikidata.org/entity/Q24644976

about

VE-statin/egfl7 expression in endothelial cells is regulated by a distal enhancer and a proximal promoter under the direct control of Erg and GATA-2 Impaired angiogenesis and altered Notch signaling in mice overexpressing endothelial Egfl7 EGFL7 is a chemoattractant for endothelial cells and is up-regulated in angiogenesis and arterial injury.Ectopic expression of miR-126*, an intronic product of the vascular endothelial EGF-like 7 gene, regulates prostein translation and invasiveness of prostate cancer LNCaP cells Ets-1 and Ets-2 regulate the expression of microRNA-126 in endothelial cells AngiomiRs--key regulators of angiogenesis Expression of EGFL7 in primordial germ cells and in adult ovaries and testes VE-statin/egfl7 regulates vascular elastogenesis by interacting with lysyl oxidases The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis MicroRNAs: promising new antiangiogenic targets in cancer Expression of epidermal growth factor‑like domain 7 may be a predictive marker of the effect of neoadjuvant chemotherapy for locally advanced uterine cervical cancer Analysis of small human proteins reveals the translation of upstream open reading frames of mRNAs Prognostic importance of circulating epidermal growth factor-like domain 7 in patients with metastatic colorectal cancer treated with chemotherapy and bevacizumab Epidermal growth factor-like domain-containing protein 7 (EGFL7) enhances EGF receptor-AKT signaling, epithelial-mesenchymal transition, and metastasis of gastric cancer cells Epidermal growth factor-like domain 7 is a marker of the endothelial lineage and active angiogenesis Deep RNA sequencing reveals novel cardiac transcriptomic signatures for physiological and pathological hypertrophy Novel expression of EGFL7 in placental trophoblast and endothelial cells and its implication in preeclampsia High expression of epidermal growth factor-like domain 7 is correlated with poor differentiation and poor prognosis in patients with epithelial ovarian cancer Intra-tumoural vessel area estimated by expression of epidermal growth factor-like domain 7 and microRNA-126 in primary tumours and metastases of patients with colorectal cancer: a descriptive study.Novel role for epidermal growth factor-like domain 7 in metastasis of human hepatocellular carcinoma.Egfl7 is differentially expressed in arteries and veins during retinal vascular development.A distinct mechanism of vascular lumen formation in Xenopus requires EGFL7 EGF-like-domain-7 is required for VEGF-induced Akt/ERK activation and vascular tube formation in an ex vivo angiogenesis assay.EGFL7: a unique angiogenic signaling factor in vascular development and disease Gene expression profiling of placentae from women with early- and late-onset pre-eclampsia: down-regulation of the angiogenesis-related genes ACVRL1 and EGFL7 in early-onset disease Epidermal growth factor-like domain 7 promotes migration and invasion of human trophoblast cells through activation of MAPK, PI3K and NOTCH signaling pathways Expression of epidermal growth factor-like domain 7 correlates with clinicopathological features of osteosarcoma High expression levels of egfl7 correlate with low endothelial cell activation in peritumoral vessels of human breast cancer.MicroRNAs as novel regulators of angiogenesis.VE-statin/Egfl7 expression in malignant glioma and its relevant molecular network Control of the adaptive immune response by tumor vasculature.EGFL7 meets miRNA-126: an angiogenesis alliance.The ets transcription factor Fli-1 in development, cancer and disease.Hypoxia Induces Multidrug Resistance via Enhancement of Epidermal Growth Factor-Like Domain 7 Expression in Non-Small Lung Cancer Cells.Altered feto-placental vascularization, feto-placental malperfusion and fetal growth restriction in mice with Egfl7 loss of function.Noncoding RNAs in Tumor Angiogenesis.Regulation of miRNA expression by Src and contact normalization: effects on nonanchored cell growth and migration.Viral nanoparticles decorated with novel EGFL7 ligands enable intravital imaging of tumor neovasculature.Endothelial Cell Activation Is Regulated by Epidermal Growth Factor-like Domain 7 (Egfl7) during Inflammation.In-vitro inhibitory effect of EGFL7-RNAi on endothelial angiogenesis in glioma.

P2860

e206b3293ad0b109079cabd49dd032e2aacadb89

P248

Q21136180-4A0E7D1F-E98C-4D5D-ABBE-5D6234232E55 Q24303364-60A85270-038C-4880-A933-55CA0D400E0A Q24545469-3B03C4C0-C83F-41BA-89A3-CBC9310C8E15 Q24604908-1D679AB6-D426-457E-BC96-CB9A3EC6F0BC Q24607999-6BDE9C7A-C7AA-4D3E-8CFD-45306FB8DF0B Q24645570-9CA82308-C16C-4476-AE75-929C336047B8 Q24651219-D4243C98-447E-44AC-ACF3-F44E419EFB51 Q24652188-5300E931-A03C-435A-96B4-10C57CDB477E Q24656947-B9B01C41-9738-4730-A33E-60AB775AC3D3 Q27027998-3F2708D6-88DA-44FA-913D-224B4D44CAB6 Q28468344-CDB8235B-4807-453B-8FD1-2AD9CD5D6A5C Q31121459-C335D349-C3D8-4775-AC7D-AC2385D5FDE3 Q33725671-C5BADD46-0138-48F2-A1A5-1257C67D9D28 Q33779037-DFF5E28A-3632-4110-99E3-F1FA16CA1766 Q33934748-61DFBEA1-609B-4D52-BC70-11A57B8FFB7F Q34241891-4D48AF4A-8961-49A3-8D85-B2FDC885EBD2 Q34255152-562C2A8B-72BF-495A-B05A-41EF270CE816 Q34330350-374644FC-CECC-41F8-B873-9229B0B80EE2 Q34996343-5D006FF5-C5F5-4170-9A98-FAF020444498 Q35007692-102DF6C6-6A61-40E5-BB93-13BE2A843F10 Q35111150-8DEEC258-57F9-4052-869A-09025B495E33 Q35112500-64D4E798-AE34-4EAC-878D-B47632BEF7F6 Q35125076-761AA9CD-C48C-42C0-8153-13A8F52CAA1A Q35776390-9CD6D276-3ADE-4FE9-B011-226E31B64661 Q35797381-81E6277A-75BF-4987-8A9C-7F0EBC0C9467 Q35821195-AB80C9B8-BCBB-45FC-9134-CAD7E356F8DE Q35993067-E935D237-5B68-4642-B7F0-6D4F38111F98 Q37107740-E0358303-4B66-41B9-AD8F-7030C8D3156D Q37383695-4DE5E372-8D1C-430D-928E-E6EDFC95DAB3 Q37676750-9B85A68C-1F5E-42CB-8E87-5A6790A711F6 Q37683575-821543FF-8542-4CC0-A80F-860721447320 Q37763307-1032A9A6-CB80-4179-BD5A-1E21CB7711B8 Q38218534-0B391F41-815C-44C1-A6B6-6E48E96F09A9 Q38709914-60FD041B-4DF2-4AD8-8A38-A2D1863375AA Q38773752-59FABC76-58A1-47E8-BB7D-FAA95FB16EFE Q38885486-0BD5D735-F575-45EC-964A-05C556AFD23F Q39797143-529CF4EC-F297-4FF8-8D13-5A136F76573E Q40086225-6E0DD07C-E493-42CE-AFDA-BD010FDE5811 Q40533421-5942CD18-73A1-4867-B1F2-85AE6C8233DC Q41851223-84438801-3B11-418E-A526-A3FD3A9D53A8

P2860

VE-statin, an endothelial repressor of smooth muscle cell migration

http://www.wikidata.org/entity/Q24644976

description

2003 nî lūn-bûn

@nan

2003 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

VE-statin, an endothelial repressor of smooth muscle cell migration

@ast

VE-statin, an endothelial repressor of smooth muscle cell migration

@en

VE-statin, an endothelial repressor of smooth muscle cell migration

@nl

type

label

VE-statin, an endothelial repressor of smooth muscle cell migration

@ast

VE-statin, an endothelial repressor of smooth muscle cell migration

@en

VE-statin, an endothelial repressor of smooth muscle cell migration

@nl

prefLabel

VE-statin, an endothelial repressor of smooth muscle cell migration

@ast

VE-statin, an endothelial repressor of smooth muscle cell migration

@en

VE-statin, an endothelial repressor of smooth muscle cell migration

@nl

P1433

Q24644976-96BFB937-6A57-4545-8368-BDC1B876F7C8

P1476

Q24644976-87CD2294-A214-43AB-A881-F2875578C636

P2093

Q24644976-6C19A9DF-DF1B-400D-8AC9-06F5731A0BFD

Q24644976-6CAE38EF-27D6-4A7B-A296-4362489668B5

Q24644976-812AB377-08E8-4458-B454-C7AC45B23856

Q24644976-9D47E08C-5FCE-4592-9E0A-F6F2750989CA

Q24644976-A30AC3F5-D7AA-4F11-A99F-F45F4F31C703

Q24644976-B8D32F4E-F11F-4C1E-AE1C-1DF4902AE1D3

Q24644976-C19E340B-8BB1-42B6-BF42-8DD30013B6BC

P2860

Q24644976-0193E38A-4E72-4FA3-BDA7-7F5B7D3FDE07

Q24644976-045D8093-B8D4-4241-9C87-FE99419A6D4F

Q24644976-0BD9F4AE-8F5F-41C6-9B6E-60F22734CAB0

Q24644976-0C33418B-0C34-4F9A-9A1C-49B688C9F1E6

Q24644976-2905FE16-9051-46CD-B916-306C03EBDB05

Q24644976-2ABB97CF-F73E-4A24-B469-389B8819C537

Q24644976-2B5CDBA3-3B49-4D54-A846-C235AD89B0A0

Q24644976-2C97D287-5024-42B3-BF55-93BAAB9585FE

Q24644976-2E3D8BD3-6A53-40FB-A271-6D2789C75973

Q24644976-2EC599D9-AD8F-465D-BC9B-0A615E01CA33

P304

Q24644976-3312564A-F468-4524-9033-8107F7EB79D6

P31

Q24644976-70EC76AA-D58C-42B2-B4FA-EFF3453BF1C3

P3181

Q24644976-D71F5781-A948-4D8F-83B1-06A900A971A2

P356

Q24644976-46FB1E56-0188-4B7B-A634-11EDF4340C49

P407

Q24644976-0215DAFA-5DD1-41D2-A1DD-93D5212CFE1C

P433

Q24644976-F29CC6C8-D04A-49C3-A761-99DF8E779864

P478

Q24644976-0948AC3D-5AB0-4645-8535-15956955195E

P50

Q24644976-C5E824F4-B69D-443E-BB1D-1E93E7AB7952

P577

Q24644976-8A9C520A-ECF2-4568-9BD7-9E7B887EDC82

P5875

Q24644976-F4AB81E5-2FAB-44AE-9EEC-A38F4FA4CD57

P698

Q24644976-5769C05F-B4D1-45A3-9E95-0412FB240615

P921

Q24644976-2B9D55EF-53FF-4850-A03B-9F2370BEC572

P932

Q24644976-8221C433-CBB4-47E1-B284-152134046BF0

P3181

P356

P1433

The EMBO Journal

P1476

VE-statin, an endothelial repressor of smooth muscle cell migration

@en

P2093

Agnès Begue

http://www.w3.org/2001/XMLSchema#string

Dominique Stehelin

http://www.w3.org/2001/XMLSchema#string

Fabrice Soncin

http://www.w3.org/2001/XMLSchema#string

Frédéric Lepretre

http://www.w3.org/2001/XMLSchema#string

Frédéric Lionneton

http://www.w3.org/2001/XMLSchema#string

Nathalie Spruyt

http://www.w3.org/2001/XMLSchema#string

Virginie Mattot

http://www.w3.org/2001/XMLSchema#string

P2860

Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning

Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis

Chemotactic properties of angiopoietin-1 and -2, ligands for the endothelial-specific receptor tyrosine kinase Tie2

Molecular cloning of a novel human cDNA encoding a zinc finger protein that binds to the interleukin-3 promoter

Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation

Edg-1, the G protein-coupled receptor for sphingosine-1-phosphate, is essential for vascular maturation

The scanning model for translation: an update

Targeted deficiency or cytosolic truncation of the VE-cadherin gene in mice impairs VEGF-mediated endothelial survival and angiogenesis

Role of vascular endothelial-cadherin in vascular morphogenesis

Defective angiogenesis in mice lacking endoglin

P304

5700-11

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

458551

http://www.w3.org/2001/XMLSchema#string

P356

10.1093/EMBOJ/CDG549

http://www.w3.org/2001/XMLSchema#string

P407

P433

21

http://www.w3.org/2001/XMLSchema#string

P478

22

http://www.w3.org/2001/XMLSchema#string

P50

Dominique Stéhelin

P577

2003-11-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

9030600

http://www.w3.org/2001/XMLSchema#string

P698

14592969

http://www.w3.org/2001/XMLSchema#string

P921

P932

275406

http://www.w3.org/2001/XMLSchema#string